Stock Analiz

Bioceres Crop Solutions Corp. BIOX

Agricultural Chemicals · data as of November 13, 2026

$0.21Market cap $13M
Open the interactive analysis →

Bioceres Crop Solutions Corp. (BIOX) is a industrial company listed in the US with a market value of about $13M. In fiscal year 2025 it had revenue of $335M and net income of -$55M, a net margin of -16.5%.

Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is shareholder returns (3/5); the weakest is future growth (0/5).

Key numbers: a price to free cash flow of 0.3, 5-year revenue growth of 14% a year, a 5-year average ROIC of 8%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 496% above the current price.

About Bioceres Crop Solutions

Bioceres Crop Solutions is listed in the US and classified in agricultural chemicals. Revenue went from $41M in 2016 to $335M in 2025, growth of about 26.2% a year. It was profitable in 3 of the last 9 years in our data.

Score: 1.4 / 5

Value2/5
Future growth0/5
Track record1/5
Financial health1/5
Shareholder returns3/5

Checks passed

  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • 5-year revenue growth above 8% a year
  • Positive free cash flow
  • Pays a dividend
  • Dividend 3 years in a row
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%

Valuation

P/E (TTM)—
Forward P/E—
P/FCF0.3
P/S0.0
P/B0.1
EV/EBITDA—
PEG—
Dividend yield0.54%
FCF yield330.3%
Shareholder yield7.4%
Intrinsic value vs. price+496%

Growth and quality

Revenue growth (1 yr)-27.9%
Revenue growth (5 yrs, per year)14.1%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-3.3%
ROIC (5-yr avg.)8.4%
Profitable years (of last 10)3
Years paying a dividend4

Financials, last 9 years

Fiscal year202520242023202220212020201920182016
Revenue$335M$465M$420M$335M$210M$173M$161M$134M$41M
Net income-$55M$4M$19M-$7M-$7M$3M-$18M-$11M-$6M
Free cash flow$44M$32M-$9M-$21M-$9M$8M$28M$16M-$2M
EPS (diluted)$-0.87$0.07$0.29$-0.11$-0.11$0.05$-0.29$-0.17$-0.09
Net margin-16.5%0.9%4.5%-2.1%-3.3%1.9%-11.4%-8.3%-14.2%
ROIC-0.4%6.1%9.2%11.5%15.8%17.0%16.8%8.5%0.2%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Bioceres Crop Solutions stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 496% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Bioceres Crop Solutions pay a dividend?

Yes. The dividend yield is about 0.54%, and it has paid dividends for 4 years in our data.

Is Bioceres Crop Solutions a good stock to buy?

We do not give buy or sell advice. Bioceres Crop Solutions scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.